Results 221 to 230 of about 38,650 (259)
Some of the next articles are maybe not open access.
Immunophenotyping by Mass Cytometry
2019Mass cytometry is a novel technology similar to flow cytometry in which antibodies are tagged with heavy metal molecules rather than fluorophores and then detected with time-of-flight mass spectrometry. This enables measurement of up to 50 simultaneous parameters with no autofluorescent background and little or no spillover or required compensation ...
openaire +2 more sources
Immunophenotyping: Analytical approaches and role in preclinical development of nanomedicines
Advanced Drug Delivery Reviews, 2022Marina A Dobrovolskaia, Hannah S Newton
exaly
Cytogenetics and Immunophenotype
Leukemia & Lymphoma, 1994C, Mecucci, H, van den Berghe
openaire +2 more sources
Standardizing immunophenotyping for the Human Immunology Project
Nature Reviews Immunology, 2012Holden T Maecker, J Philip Mccoy
exaly
2016
Immunophenotyping is, by definition, to classify and subclassify the cells by using monoclonal antibodies (Mabs) raised against cell surface antigens. These antigens may be helpful to discriminate morphologically indistinguishable cells. Immunophenotyping has been used in clinical practice for many years and it became an indispensable diagnostic aid ...
openaire +1 more source
Immunophenotyping is, by definition, to classify and subclassify the cells by using monoclonal antibodies (Mabs) raised against cell surface antigens. These antigens may be helpful to discriminate morphologically indistinguishable cells. Immunophenotyping has been used in clinical practice for many years and it became an indispensable diagnostic aid ...
openaire +1 more source
2018
To revisit the nosography of diseases from the Auto-inflammatory to Autoimmune Continuum Diseases through clinical and biological co-investigations (deep phenotyping) and identify subgroups of patients that cut-across their diagnostic groups 2. To discover biomarkers for these subgroups of patients 3.
openaire +1 more source
To revisit the nosography of diseases from the Auto-inflammatory to Autoimmune Continuum Diseases through clinical and biological co-investigations (deep phenotyping) and identify subgroups of patients that cut-across their diagnostic groups 2. To discover biomarkers for these subgroups of patients 3.
openaire +1 more source

